Refine by
Guided Surgery Articles & Analysis
50 news found
These NIR quantum dots can be used in biological applications, such as fluorescence imaging, fluorescence quenching and enhancement based bioanalytical detection, molecular detection based on electrogenerated chemiluminescence, traceable drug delivery, fluorescence-activated cell sorting (FACS), precise diagnosis, and image-guided surgery. Currently, CD ...
Until now, the only way to remove a mass from the heart was via open heart surgery, which the St. Cloud Hospital cardiology team deemed too risky for the patient. ...
OnLume Inc., a Madison, Wisconsin-based medical imaging company with unique technology for improving surgical precision in the operating room, has announced the start of participation in a clinical trial combining its fluorescence-guided surgery (FGS) imaging device with a novel nerve-targeting agent. ...
National Institutes of Health (NIH)’s National Cancer Institute (NCI) to advance development of its proprietary device for Fluorescence-Guided Surgery (FGS). OnLume has developed novel FGS imaging technology to illuminate critical anatomy in real-time during surgery to optimize precision, which can lead to improved patient outcomes, ...
Food & Drug Administration (“FDA”) to market its first product, a fluorescence guided surgery (FGS) system. The OnLume Imaging System is indicated for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive, and micro surgeries. This ...
EchoPixel has had a long-standing relationship with Stanford physicians, who were early adopters of its technology, beginning with the successful surgery of the conjoined Sandoval twins in 2017. The affiliation has continued in partnership with Michael Ma, MD, Assistant Professor of Cardiothoracic Surgery in the Division of Pediatric Cardiac ...
Basilion delivered papers focused on the use of molecular probes for guided, precision surgery to the European Society of Molecular Imaging, the World Society of Molecular Imaging, and the Netherlands Science ...
“We have been at the forefront of image-guided surgery with novel molecular markers and advanced imaging modalities for several years. ...
Small lesions in the lung are notoriously hard to locate during surgery. With broad application in radio-guided surgery across multiple procedures and major cancer types, SENSEI is currently in use worldwide in prostate, cervical, and colorectal cancer surgery. ...
Fluoroscopy is a common tool for image-guided interventions in 50 million surgeries performed annually in the US alone. ...
SurgiMAb is very happy to participate in person to this exciting conference that will gather together the best KOLs in the domain. After two years of remote interactions, this conference will be a great occasion to discover exciting novelties and discuss collaborations in person. Don’t miss the talks by Hiroto Nishino 22 January 2022 • 4:15 PM and Françoise Cailler, CEO and ...
BySurgiMab
(NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today provided a preliminary 2021 year-end corporate update. ...
Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. ...
Previously it had received NMPA approval for Navient ENT model. Navient, an image-guided surgical navigation system, is like a GPS for the surgeon to navigate inside the patient skull. ...
ByClaroNav
(NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced Private Healthcare Institution Railway Clinical Hospital RZD Medicine of Rostov-on-Don (“RZD Medicine”), located in Rostov, Russia, has initiated its ...
(NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the Franklin Medical Center in Winnsboro, Louisiana has entered into an agreement to lease and utilize a Senhance® Surgical System. ...
(NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the third quarter 2021. ...
(NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the Shinmatsudo Central General Hospital in Matsudo, Japan has entered into an agreement to lease and utilize a Senhance® Surgical System. ...
(NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2021 third quarter financial and operating results after the market closes on Wednesday, November 3, 2021. ...
Avelas is developing pegloprastide (AVB-620), a novel fluorescent imaging agent used in combination with a fluorescence camera system, which has FDA Breakthrough Therapy Designation, for the intraoperative detection and visualization of positive margins during breast cancer surgery. The goal of intraoperative image-guided surgery with ...